Top Researchers
Top Medicine Researchers at University of Manchester for 2026
The University of Manchester’s recent Medicine research spans clinical care, population health, and method-focused work that connects bedside questions with broader health outcomes. Across a large sample of publications, the institution’s researchers were active in areas ranging from cardiovascular risk and genetics to rheumatology, obstetrics, and oncology.
Below, you’ll find a snapshot of the people shaping that output over the last year, with a look at the topics they are publishing on and the directions those studies suggest for practice, policy, and future research.
Featured Researchers
Evangelos Kontopantelis
Evangelos Kontopantelis has recently focused on general health professions, cardiology and cardiovascular medicine, and epidemiology, with publications on modifiable cardiovascular risk factors, cardiac outcomes, and burnout among general practitioners.
Activity over the last year: 29 indexed journal articles.
Top publications:
- The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050 (Jul 2025)
- Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis (Mar 2025)
- Associations between burnout and career disengagement factors among general practitioners: a path analysis (Jun 2025)
D. Gareth Evans
D. Gareth Evans has been publishing across genetics, neurology, and pathology and forensic medicine, with recent work on breast cancer multigene panel testing, polygenic risk scores, and communicating risk to patients.
Activity over the last year: 25 indexed journal articles.
Top publications:
- Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendations (Jun 2025)
- Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores (Mar 2025)
- Psychological and emotional impacts of communicating breast cancer risk using multifactorial assessment with polygenic risk score: Findings from PERSPECTIVE I&I (May 2025)
Sizheng Steven Zhao
Sizheng Steven Zhao’s recent work links rheumatology, immunology, and psychiatry and mental health, including studies on TriNetX methods, the safety of JAK inhibitors, and genetic risk factors for sarcoidosis.
Activity over the last year: 17 indexed journal articles.
Top publications:
- A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX (Mar 2025)
- Comparative safety of JAK inhibitors versus TNF or IL-17 inhibitors for cardiovascular disease and cancer in psoriatic arthritis and axial spondyloarthritis (Feb 2025)
- GWAS identifies genetic loci, lifestyle factors and circulating biomarkers that are risk factors for sarcoidosis (Mar 2025)
Alexander Heazell
Alexander Heazell has been active in obstetrics and gynecology, clinical psychology, and pediatrics, with recent publications on autism profiles, adverse pregnancy outcomes, and management for reduced fetal movement.
Activity over the last year: 22 indexed journal articles.
Top publications:
- Polygenic and developmental profiles of autism differ by age at diagnosis (Oct 2025)
- Risk Factors for Adverse Pregnancy Outcomes in Reduced Fetal Movement: An IPD Meta‐Analysis (Mar 2025)
- Cerebroplacental ratio-based management versus care as usual in non-small-for-gestational-age fetuses at term with maternal perceived reduced fetal movements (CEPRA): a multicentre, cluster-randomised controlled trial (Jul 2025)
Hareesha Rishab Bharadwaj
Hareesha Rishab Bharadwaj has worked across oncology, public health, environmental and occupational health, and emergency medical services, with recent reviews on AI-assisted capsule endoscopy, Zenker’s diverticulum, and gastroenteritis.
Activity over the last year: 23 indexed journal articles.
Top publications:
- Artificial Intelligence–Assisted Capsule Endoscopy Versus Conventional Capsule Endoscopy for Detection of Small Bowel Lesions: A Systematic Review and Meta‐Analysis (Mar 2025)
- Management Strategies for Zenker’s Diverticulum: A Comprehensive Review (Aug 2025)
- Updates and Current Knowledge on the Common Forms of Gastroenteritis: A Review (May 2025)
Philip A. Kalra
Philip A. Kalra has focused on nephrology and pulmonary and respiratory medicine, including studies on KIM-1 in chronic kidney disease, uncoded CKD prevalence, and personalized care in CKD.
Activity over the last year: 20 indexed journal articles.
Top publications:
- Plasma and Urinary KIM-1 in Chronic Kidney Disease: Prognostic Value, Associations with Albuminuria, and Implications for Kidney Failure and Mortality (Aug 2025)
- Uncoded chronic kidney disease prevalence in secondary care: a retrospective audit with population health implications (Jan 2025)
- Personalized Care in CKD: Moving Beyond Traditional Biomarkers (Jan 2025)
Ananya Choudhury
Ananya Choudhury’s recent publications sit at the intersection of surgery, radiation, and pulmonary and respiratory medicine, including bladder preservation strategies and trial reports from prostate cancer treatment.
Activity over the last year: 23 indexed journal articles.
Top publications:
- Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group (Apr 2025)
- Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial (May 2025)
- Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis (Jan 2025)
Matthew Harries
Matthew Harries has been publishing in urology, dermatology, and pathology and forensic medicine, with work on alopecia areata, frontal fibrosing alopecia, and real-world disease registries.
Activity over the last year: 19 indexed journal articles.
Top publications:
- Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia (Feb 2025)
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial (Feb 2025)
- The Global Register of Alopecia areata disease Severity and treatment Safety – United Kingdom (GRASS-UK): importance of real-world data in alopecia areata (Feb 2025)
What University of Manchester's Medicine Community Is Working On
The strongest themes in this group’s Medicine research are pathology and forensic medicine, alongside pulmonary and respiratory medicine, with general health professions, cardiology and cardiovascular medicine, and epidemiology also appearing prominently. That mix suggests a community balancing specialist clinical questions with broader health systems, risk, and outcomes work. Recent publications point to active interest in prevention, personalization, real-world data, and trial-based decision-making, showing how research at the University of Manchester is engaged with both patient care and the evidence needed to improve it.- Pathology and Forensic Medicine - seen across 2 of the featured researchers
- Pulmonary and Respiratory Medicine - seen across 2 of the featured researchers
- General Health Professions - seen across 1 of the featured researchers
- Cardiology and Cardiovascular Medicine - seen across 1 of the featured researchers
- Epidemiology - seen across 1 of the featured researchers
Taken together, these researchers show how Medicine at the University of Manchester reaches across specialties while staying closely tied to real clinical questions. If you want to keep tracking publication patterns, identify active collaborators, or streamline your own writing and submission workflow, Resub can help support the research process from draft to delivery.
Top researchers use tools to scale their productivity and impact. Try Livewrite for free today.